• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIO
Click for more information
2.26% 68.0¢

BIOME AUSTRALIA LIMITED - Announcements

Market Cap $149.0M  ! watchlist Created with Sketch. Add to my watchlist
Consumer Defensive Household & Personal Products

Biome Australia Ltd is an Australia-based microbiome health company. The Company... Biome Australia Ltd is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
BIO Record quarterly sales revenue for Q1PRICE SENSITIVE01/10/24 download Created with Sketch. 230.86KB
BIO Vision 27 Strategic Plan PresentationPRICE SENSITIVE30/09/24 download Created with Sketch. 12.66MB
BIO Biome Commences Test Market In CanadaPRICE SENSITIVE19/09/24 download Created with Sketch. 239.71KB
BIO Q1 FY25 Revenue GuidancePRICE SENSITIVE03/09/24 download Created with Sketch. 215.6KB
BIO Company PresentationPRICE SENSITIVE26/08/24 download Created with Sketch. 10.87MB
BIO Amended Preliminary Financial ReportPRICE SENSITIVE26/08/24 download Created with Sketch. 373.14KB
BIO Financial Year 2024 Key ResultsPRICE SENSITIVE26/08/24 download Created with Sketch. 271.36KB
BIO Preliminary Final ReportPRICE SENSITIVE26/08/24 download Created with Sketch. 257.01KB
BIO Clinically Proven Cholesterol Reducing Probiotic LaunchedPRICE SENSITIVE19/08/24 download Created with Sketch. 238.67KB
BIO Biome shares three-year revenue targetPRICE SENSITIVE29/07/24 download Created with Sketch. 219.98KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE15/07/24 download Created with Sketch. 1MB
BIO Biome Achieves Record Sales Revenue in FY24PRICE SENSITIVE01/07/24 download Created with Sketch. 263.63KB
BIO Biome expects to exceed FY24 forecastPRICE SENSITIVE12/06/24 download Created with Sketch. 241.91KB
BIO International Market Update and Health Canada approvalsPRICE SENSITIVE29/05/24 download Created with Sketch. 256.74KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE11/04/24 download Created with Sketch. 1.48MB
BIO Non-Deal Investor Presentation April 2024PRICE SENSITIVE11/04/24 download Created with Sketch. 12.23MB
BIO First Quarter of Positive Underlying Cash FlowPRICE SENSITIVE02/04/24 download Created with Sketch. 238.28KB
BIO Biome Releases First Half FY2024 ResultsPRICE SENSITIVE22/02/24 download Created with Sketch. 266.34KB
BIO Appendix 4D & Half Yearly ReportPRICE SENSITIVE22/02/24 download Created with Sketch. 725.36KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE22/01/24 download Created with Sketch. 1.5MB
BIO Biome to launch into UK and Ireland health retailPRICE SENSITIVE15/01/24 download Created with Sketch. 245.64KB
BIO FY24 Revenue Guidance Upgrade to $12.5MPRICE SENSITIVE08/01/24 download Created with Sketch. 328.44KB
BIO Biome Achieves Record Quarter and Half Year SalesPRICE SENSITIVE02/01/24 download Created with Sketch. 303.11KB
BIO Biome to launch cholesterol reducing probioticPRICE SENSITIVE21/12/23 download Created with Sketch. 255.54KB
BIO Biome signs landmark agreement to develop IPPRICE SENSITIVE11/12/23 download Created with Sketch. 330.05KB
BIO Revenue UpdatePRICE SENSITIVE28/11/23 download Created with Sketch. 459.48KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE24/10/23 download Created with Sketch. 1.84MB
BIO Biome expects first month of positive EBITDA in FY24PRICE SENSITIVE09/10/23 download Created with Sketch. 289.56KB
BIO Trading UpdatePRICE SENSITIVE03/10/23 download Created with Sketch. 265.5KB
BIO Preliminary Final ReportPRICE SENSITIVE24/08/23 download Created with Sketch. 270.33KB
BIO Trading UpdatePRICE SENSITIVE31/07/23 download Created with Sketch. 317.33KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE31/07/23 download Created with Sketch. 1.45MB
BIO Biome Lift Clinical Trial PresentationPRICE SENSITIVE06/07/23 download Created with Sketch. 2.89MB
BIO Biome Lift trial update positive results receivedPRICE SENSITIVE06/07/23 download Created with Sketch. 251.94KB
BIO Full year revenue guidance FY23PRICE SENSITIVE04/07/23 download Created with Sketch. 241.7KB
BIO Biome secures $1.2 million revolving debt facilityPRICE SENSITIVE28/06/23 download Created with Sketch. 279.82KB
BIO Biome surpasses $7m sales revenue targetPRICE SENSITIVE15/06/23 download Created with Sketch. 230.22KB
BIO Correction to Quarterly Activities ReportPRICE SENSITIVE20/04/23 download Created with Sketch. 256.4KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE20/04/23 download Created with Sketch. 1.4MB
BIO 'Biome delivers record quarterly sales in Q3 FY23PRICE SENSITIVE03/04/23 download Created with Sketch. 324.71KB
BIO Biome signs corporate advisory mandate with Canary CapitalPRICE SENSITIVE31/03/23 download Created with Sketch. 358.73KB
BIO Biome H1 FY23 Investor PresentationPRICE SENSITIVE06/03/23 download Created with Sketch. 4.11MB
BIO Appendix 4D & Half Yearly ReportPRICE SENSITIVE28/02/23 download Created with Sketch. 578.35KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE30/01/23 download Created with Sketch. 1.42MB
BIO Biome records record H1 sales revenuePRICE SENSITIVE09/01/23 download Created with Sketch. 305.1KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE27/10/22 download Created with Sketch. 1.01MB
BIO FY23 Q1 Sales Revenue Update and FY23 ForecastPRICE SENSITIVE04/10/22 download Created with Sketch. 231.31KB
BIO FY22 Company PresentationPRICE SENSITIVE04/10/22 download Created with Sketch. 3.19MB
BIO FY23 Trading UpdatePRICE SENSITIVE21/09/22 download Created with Sketch. 186.56KB
BIO Biome Lift Clinical Trial Hits Recruitment TargetPRICE SENSITIVE01/09/22 download Created with Sketch. 210.57KB
BIO Delivery of Activated Probiotics to 370 Priceline PharmaciesPRICE SENSITIVE31/08/22 download Created with Sketch. 201.57KB
BIO Preliminary Final ReportPRICE SENSITIVE29/08/22 download Created with Sketch. 310.02KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE26/07/22 download Created with Sketch. 926.97KB
BIO FY22 Revenue GuidancePRICE SENSITIVE04/07/22 download Created with Sketch. 197.9KB
BIO Biome signs distribution agreement with Priceline PharmacyPRICE SENSITIVE30/05/22 download Created with Sketch. 212.87KB
BIO FY22 Trading UpdatePRICE SENSITIVE18/05/22 download Created with Sketch. 170.86KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE20/04/22 download Created with Sketch. 1.12MB
BIO Record H1 sales deliver 98% revenue growthPRICE SENSITIVE28/02/22 download Created with Sketch. 342.04KB
BIO Appendix 4D and Half Yearly ReportPRICE SENSITIVE28/02/22 download Created with Sketch. 582.54KB
BIO Ethics approval received for Biome Daily Kids clinical trialPRICE SENSITIVE24/02/22 download Created with Sketch. 1.32MB
BIO Biome Clinical Development UpdatePRICE SENSITIVE21/02/22 download Created with Sketch. 1.23MB
BIO Supplementary announcement Acne clinical trialPRICE SENSITIVE14/02/22 download Created with Sketch. 423.41KB
BIO Successful acne clinical trial result with product to launchPRICE SENSITIVE09/02/22 download Created with Sketch. 280.02KB
BIO Clinical trial on asthma sufferers validates Biome probioticPRICE SENSITIVE02/02/22 download Created with Sketch. 371.1KB
BIO Quarterly Activities & Cashflow ReportPRICE SENSITIVE24/01/22 download Created with Sketch. 2.2MB
BIO Investor UpdatePRICE SENSITIVE03/12/21 download Created with Sketch. 357.26KB
BIO Record quarterly sales revenue for Q1
01/10/24PRICE SENSITIVE download Created with Sketch. 230.86KB
BIO Vision 27 Strategic Plan Presentation
30/09/24PRICE SENSITIVE download Created with Sketch. 12.66MB
BIO Biome Commences Test Market In Canada
19/09/24PRICE SENSITIVE download Created with Sketch. 239.71KB
BIO Q1 FY25 Revenue Guidance
03/09/24PRICE SENSITIVE download Created with Sketch. 215.6KB
BIO Company Presentation
26/08/24PRICE SENSITIVE download Created with Sketch. 10.87MB
BIO Amended Preliminary Financial Report
26/08/24PRICE SENSITIVE download Created with Sketch. 373.14KB
BIO Financial Year 2024 Key Results
26/08/24PRICE SENSITIVE download Created with Sketch. 271.36KB
BIO Preliminary Final Report
26/08/24PRICE SENSITIVE download Created with Sketch. 257.01KB
BIO Clinically Proven Cholesterol Reducing Probiotic Launched
19/08/24PRICE SENSITIVE download Created with Sketch. 238.67KB
BIO Biome shares three-year revenue target
29/07/24PRICE SENSITIVE download Created with Sketch. 219.98KB
BIO Quarterly Activities & Cashflow Report
15/07/24PRICE SENSITIVE download Created with Sketch. 1MB
BIO Biome Achieves Record Sales Revenue in FY24
01/07/24PRICE SENSITIVE download Created with Sketch. 263.63KB
BIO Biome expects to exceed FY24 forecast
12/06/24PRICE SENSITIVE download Created with Sketch. 241.91KB
BIO International Market Update and Health Canada approvals
29/05/24PRICE SENSITIVE download Created with Sketch. 256.74KB
BIO Quarterly Activities & Cashflow Report
11/04/24PRICE SENSITIVE download Created with Sketch. 1.48MB
BIO Non-Deal Investor Presentation April 2024
11/04/24PRICE SENSITIVE download Created with Sketch. 12.23MB
BIO First Quarter of Positive Underlying Cash Flow
02/04/24PRICE SENSITIVE download Created with Sketch. 238.28KB
BIO Biome Releases First Half FY2024 Results
22/02/24PRICE SENSITIVE download Created with Sketch. 266.34KB
BIO Appendix 4D & Half Yearly Report
22/02/24PRICE SENSITIVE download Created with Sketch. 725.36KB
BIO Quarterly Activities & Cashflow Report
22/01/24PRICE SENSITIVE download Created with Sketch. 1.5MB
BIO Biome to launch into UK and Ireland health retail
15/01/24PRICE SENSITIVE download Created with Sketch. 245.64KB
BIO FY24 Revenue Guidance Upgrade to $12.5M
08/01/24PRICE SENSITIVE download Created with Sketch. 328.44KB
BIO Biome Achieves Record Quarter and Half Year Sales
02/01/24PRICE SENSITIVE download Created with Sketch. 303.11KB
BIO Biome to launch cholesterol reducing probiotic
21/12/23PRICE SENSITIVE download Created with Sketch. 255.54KB
BIO Biome signs landmark agreement to develop IP
11/12/23PRICE SENSITIVE download Created with Sketch. 330.05KB
BIO Revenue Update
28/11/23PRICE SENSITIVE download Created with Sketch. 459.48KB
BIO Quarterly Activities & Cashflow Report
24/10/23PRICE SENSITIVE download Created with Sketch. 1.84MB
BIO Biome expects first month of positive EBITDA in FY24
09/10/23PRICE SENSITIVE download Created with Sketch. 289.56KB
BIO Trading Update
03/10/23PRICE SENSITIVE download Created with Sketch. 265.5KB
BIO Preliminary Final Report
24/08/23PRICE SENSITIVE download Created with Sketch. 270.33KB
BIO Trading Update
31/07/23PRICE SENSITIVE download Created with Sketch. 317.33KB
BIO Quarterly Activities & Cashflow Report
31/07/23PRICE SENSITIVE download Created with Sketch. 1.45MB
BIO Biome Lift Clinical Trial Presentation
06/07/23PRICE SENSITIVE download Created with Sketch. 2.89MB
BIO Biome Lift trial update positive results received
06/07/23PRICE SENSITIVE download Created with Sketch. 251.94KB
BIO Full year revenue guidance FY23
04/07/23PRICE SENSITIVE download Created with Sketch. 241.7KB
BIO Biome secures $1.2 million revolving debt facility
28/06/23PRICE SENSITIVE download Created with Sketch. 279.82KB
BIO Biome surpasses $7m sales revenue target
15/06/23PRICE SENSITIVE download Created with Sketch. 230.22KB
BIO Correction to Quarterly Activities Report
20/04/23PRICE SENSITIVE download Created with Sketch. 256.4KB
BIO Quarterly Activities & Cashflow Report
20/04/23PRICE SENSITIVE download Created with Sketch. 1.4MB
BIO 'Biome delivers record quarterly sales in Q3 FY23
03/04/23PRICE SENSITIVE download Created with Sketch. 324.71KB
BIO Biome signs corporate advisory mandate with Canary Capital
31/03/23PRICE SENSITIVE download Created with Sketch. 358.73KB
BIO Biome H1 FY23 Investor Presentation
06/03/23PRICE SENSITIVE download Created with Sketch. 4.11MB
BIO Appendix 4D & Half Yearly Report
28/02/23PRICE SENSITIVE download Created with Sketch. 578.35KB
BIO Quarterly Activities & Cashflow Report
30/01/23PRICE SENSITIVE download Created with Sketch. 1.42MB
BIO Biome records record H1 sales revenue
09/01/23PRICE SENSITIVE download Created with Sketch. 305.1KB
BIO Quarterly Activities & Cashflow Report
27/10/22PRICE SENSITIVE download Created with Sketch. 1.01MB
BIO FY23 Q1 Sales Revenue Update and FY23 Forecast
04/10/22PRICE SENSITIVE download Created with Sketch. 231.31KB
BIO FY22 Company Presentation
04/10/22PRICE SENSITIVE download Created with Sketch. 3.19MB
BIO FY23 Trading Update
21/09/22PRICE SENSITIVE download Created with Sketch. 186.56KB
BIO Biome Lift Clinical Trial Hits Recruitment Target
01/09/22PRICE SENSITIVE download Created with Sketch. 210.57KB
BIO Delivery of Activated Probiotics to 370 Priceline Pharmacies
31/08/22PRICE SENSITIVE download Created with Sketch. 201.57KB
BIO Preliminary Final Report
29/08/22PRICE SENSITIVE download Created with Sketch. 310.02KB
BIO Quarterly Activities & Cashflow Report
26/07/22PRICE SENSITIVE download Created with Sketch. 926.97KB
BIO FY22 Revenue Guidance
04/07/22PRICE SENSITIVE download Created with Sketch. 197.9KB
BIO Biome signs distribution agreement with Priceline Pharmacy
30/05/22PRICE SENSITIVE download Created with Sketch. 212.87KB
BIO FY22 Trading Update
18/05/22PRICE SENSITIVE download Created with Sketch. 170.86KB
BIO Quarterly Activities & Cashflow Report
20/04/22PRICE SENSITIVE download Created with Sketch. 1.12MB
BIO Record H1 sales deliver 98% revenue growth
28/02/22PRICE SENSITIVE download Created with Sketch. 342.04KB
BIO Appendix 4D and Half Yearly Report
28/02/22PRICE SENSITIVE download Created with Sketch. 582.54KB
BIO Ethics approval received for Biome Daily Kids clinical trial
24/02/22PRICE SENSITIVE download Created with Sketch. 1.32MB
BIO Biome Clinical Development Update
21/02/22PRICE SENSITIVE download Created with Sketch. 1.23MB
BIO Supplementary announcement Acne clinical trial
14/02/22PRICE SENSITIVE download Created with Sketch. 423.41KB
BIO Successful acne clinical trial result with product to launch
09/02/22PRICE SENSITIVE download Created with Sketch. 280.02KB
BIO Clinical trial on asthma sufferers validates Biome probiotic
02/02/22PRICE SENSITIVE download Created with Sketch. 371.1KB
BIO Quarterly Activities & Cashflow Report
24/01/22PRICE SENSITIVE download Created with Sketch. 2.2MB
BIO Investor Update
03/12/21PRICE SENSITIVE download Created with Sketch. 357.26KB
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
68.0¢ 		Change
0.015(2.26%) 		Mkt cap ! $149.0M
Open High Low Value Volume
66.5¢ 69.0¢ 66.0¢ $173.2K 255.3K

Buyers (Bids)

No. Vol. Price($)
3 46226 68.0¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 83602 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
Last
68.5¢ 		  Change
0.015 ( 2.36 %)
Open High Low Volume
67.0¢ 69.0¢ 66.5¢ 99069
Last updated 15.54pm 04/10/2024 ?
BIO (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation After just over a week, the thrill China’s latest stimulus announcements put into world markets has started to subside.
Solstice Minerals to ramp up drilling campaign at Yarri Gold Project Solstice Minerals (ASX:SLS) shares were up nearly 2.5% in afternoon trades on Friday as it announced drilling plans at Yarri.
BCI reaches close of funding facility for salt-first part of Mardie project BCI Minerals Ltd has achieved financial close on a Syndicated Facility Agreement worth $981 million for its Mardie project in WA
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.